Modulation of connexin-43 by omega-3 fatty acids in the aorta of old spontaneously hypertensive rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 3, 2009, Pages 63-69

  Dlugosova, K ^a   Okruhlicova, Ludmila ^a   Mitasikova, M ^a   Sotnikova, R ^b   Bernatova, I ^a   Weismann, P ^c   Slezak, J ^a   Tribulova, N ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Aorta; Connexin 43; Hypertension; Microscopy; Omega 3 fatty acids

Indexed keywords

CONNEXIN 43; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HYPERTENSION; IMMUNOFLUORESCENCE; LIPID DIET; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

AGING; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; BLOTTING, WESTERN; CONNEXIN 43; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FLUORESCENT ANTIBODY TECHNIQUE; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; RATS; RATS, INBRED LEW; RATS, INBRED SHR;

EID: 70350241259     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Tribulova N, Knezl V, Okruhlicova L, Slezak J. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol Res 2008; 57: 1-14.
2. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in patients with coronary artery disease. J Cardiovasc Pharmacol 1999; 33: 633-640. (Pubitemid 29164828)
3. Demaison L, Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 2002; 59: 463-477. (Pubitemid 34267387)
4. Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal 2009; 11: 251-266.
5. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009; 11: 267-282.
6. VanKempen MJ, Jongsma HJ. Distribution of connexin 37, connexin 40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999; 112: 479-486.
7. Watts SW, Webb RC. Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension. Hyperetension 1996; 28: 888-893.
8. Haefliger JA, Castillo E, Waeber G, et al. Hypertension increases connexin-43 in a tissue-specific manner. Circulation 1997; 95: 1007-1014. (Pubitemid 27091547)
9. Haefliger JA, Meda P, Formenton A, et al. D. Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase. Arterioscler Thromb Vasc Biol 1999; 19: 1615-1622. (Pubitemid 29323819)
10. Rummery NM, Hill CE. Vascular gap junctions and implications for hypertension. Clin Exp Pharm Phys 2004; 31: 659-667. (Pubitemid 39540314)
11. Yeh HI, Chang HN, Lu WW, et al. Age-dependent alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 2000; 48: 1377-1388.
12. Zhang JH, Morita I, Yao XS, Murota S. Pretreatment with eicosapentaenoic acid prevents hypoxia/reoxygenationinduced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 33-40. (Pubitemid 29401611)
13. Morita I, Yhang ZW, Murota SI. Eicosapentaenoic acid protects endothelial cells function injured by hypoxia/reoxygenation. Ann N Y Acad Sci 2001; 947: 394-397. (Pubitemid 34059944)
14. Sotnikova R, Okruhlicova L, Dlugosova K, et al. Effect of n- 3 PUFA on endothelium-dependent relaxation of the superior mesenteric artery. In: Proceedings of Experimental Approaches in Basic Research and Diagnostic of Diseases: Tailoring the Treatment. Tribulova N, Okruhlicova L, Slezak J. (eds). VEDA Bratislava 2008, pp.127-134.
15. Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NOdeficient hypertension. Am J Physiol 2002; 282: H942-H948. (Pubitemid 34654931)
16. Dlugosova K, Fialova-Mitasikova M, Bernatova I, Weismann P, Okruhlicova L. Reduced connexin-43 expression in the aorta of pre-hypertensive rats. Physiol Res 2008; 57: 23-30.
17. Christ GJ, Spray DC, El-Sabban M, Moore LK, Brink PR. Gap junction in vascular tissues: evaluating the role of the intercellular communication in the modulation of vasomotor tone. Circ Res 1996; 79: 631-646. (Pubitemid 26317811)
18. Ronchi FA, Andrade MC, Carmona AK, Krieger JE, Casarini DE. N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hyperteniverats. J Hypertens 2005; 23: 1869-1878.
19. Rivera P, Ocaranza MP, Lavandero S, Jalil JE. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels. Hypertension 2007; 50: 792-798. (Pubitemid 47442747)
20. Hausler A, Girard J, Baumann JB, Ruch W, Otten UH. Longterm effects of betamethasone on blood pressure and hypothalamo-pitutary-adrenocortical function in spontaneously and normotensive rats. Horm Res 1983; 18: 191-197. (Pubitemid 14245221)
21. Amario A, Gavalda A, Marti J. Comparison of the behavioral and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinol 1995; 20: 879-890.
22. Kasacka I, Majewski M. An immunohistochemical study of endocrine cells in the stomach of hypertensive rats. J Physiol Pharmacol 2007; 58: 469-478. (Pubitemid 47523090)
23. Kasacka I, Majewski M. Can doxazosin inhibit the hypertension-induced changes of endocrine cells in the stomach of spontaneously hypertensive rats? J Physiol Pharmacol 2008; 59: 189-201.
24. Ramos A, Kangersko AL, Basso PF, et al. RN. Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. Behaviour Brain Res 2002; 129: 113-123. (Pubitemid 34059233)
25. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345-356. (Pubitemid 38496547)
26. Bernatova I, Czizmadiova Z, Kopincova J, Puzserova A. Vascular function and nitric oxide in chronic social-streeexposed rats with various family history of hypertension. J Physiol Pharmacol 2007; 58: 487-501. (Pubitemid 47523092)
27. Rummery NM, Hill CE. Vascular gap junctions and implication for hypertension. Clin Exp Pharmacol Physiol 2004; 32: 659-667.
28. Reidy MA. Proliferation of smooth muscle cells at sites distant from vascular injury. Arteriosclerosis 1990; 10: 298-305. (Pubitemid 20103593)
29. Rennick RE, Connat JL, Burnstock G, Rothery S, Severs NJ, Green CR. Expression of connexin 43 gap junctions between cultured vascular smooth muslce cells is dependent upon phenotype. Cell Tissue Res 1993; 271: 323-332. (Pubitemid 23077903)
30. Harris WS, Rambjor GS, Windsor SL, Diederich D. N-3 fatty acids and urinary excretion of nitric oxide metabolites in human. Am J Clin Nutr 1997; 65: 459-464. (Pubitemid 27130754)
31. Codde JP, Croft KD, Barden A, Mathew E, Vandongen R, Beilin LJ. An inhibitory effect of dietary polyunsaturated fatty acids on renin secretion in the isolated perfused rat kidney. J Hypertens 1984; 2: 265-270. (Pubitemid 14077403)
32. Jayasooriya AP, Begg DP, Chen N, et al. Omega-3 polyunsaturated fatty acids supplementation reduces hypertension in TG/mRen-2/27 rats. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 67-72.
33. Kansui Y, Fujii K, Nakamura K, et al. Angiotensin II receptor blockade corrects altered expression of gap junction in vascular endothelial cells from hypertensive rats. Am J Physiol 2004; 287: H216-H224. (Pubitemid 38802356)
34. Yao J, Hiramatsu N, Zhu Y, et al. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesenglial cells. J Am Soc Nephrol 2005; 16: 58-67. (Pubitemid 43073157)
35. Radovits T. Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing. Orv Hetil 2008; 149: 2377-2385.
36. Mitasikova M, Smidova S, Macsaliova A, et al. N. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol Res 2008; 57: 39-48.
37. Leaf A, Xiao YF. The modulation of ionic currents in excitable tissues by n-3 polyunsaturated fatty acids. J Membr Biol 2001; 184: 263-271. (Pubitemid 34033081)
38. Rossary A, Arab K, Goudable J, Steghens JP. Fatty acids regulate NOX activity. Ann Biol Clin (Paris) 2007; 65(1): 33-40.
39. Upham BL, Trosko JF. Oxidative-dependent integration of signal transducion with intercellular gap junctional communication in the control of gene expression. Antioxid Redox Signal 2009; 11: 297-307.
40. Madamanchi NR, Vendrov A, Runge M. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
41. DeCaterina R, Bernini W, Carluccio MA, Liao JK, Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998; 39: 1062-1070. (Pubitemid 28222012)
42. Kiec-Wilk B, Dembinska-Kiec A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K. The selected pathophysiological aspects of PPARs activation. J Physiol Pharmacol 2005; 56: 149-162. (Pubitemid 40911084)
43. Bahrami G, Ghanbarian E, Masoumi M, Rahimi Z, Rezwan Madani F. Comparison of fatty acid profiles of aorta and internal mammary arteries in patients with coronary artery disease. Clin Chim Acta 2006; 370: 143-146. (Pubitemid 44080183)